[
  {
    "title": "透景生命(300642.SZ)：透景诊断和湖南透景共计22个产品拟中选肝功生化类检测试剂省际联盟集采",
    "href": "http://stock.jrj.com.cn/2023/01/04203237259473.shtml",
    "datetime": "2023-01-04 20:32:10",
    "code": "300642"
  },
  {
    "title": "透景生命：子公司拟中选肝功生化类检测试剂省际联盟集采",
    "href": "http://stock.jrj.com.cn/2023/01/04201837259434.shtml",
    "datetime": "2023-01-04 20:18:10",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：14个产品取得泰国医疗器械注册认证",
    "href": "http://stock.jrj.com.cn/2022/12/14192137212876.shtml",
    "datetime": "2022-12-14 19:21:04",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：拟1000万元投资上海拾聚盈萃基金",
    "href": "http://stock.jrj.com.cn/2022/12/12193437206883.shtml",
    "datetime": "2022-12-12 19:34:16",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：拟4.26亿元投建总部及产业化基地",
    "href": "http://stock.jrj.com.cn/2022/12/12193037206886.shtml",
    "datetime": "2022-12-12 19:30:51",
    "code": "300642"
  },
  {
    "title": "透景生命拟投资4.26 亿元建设总部及产业化基地",
    "href": "http://stock.jrj.com.cn/2022/12/12185037206719.shtml",
    "datetime": "2022-12-12 18:50:53",
    "code": "300642"
  },
  {
    "title": "透景生命：拟4.26亿元投建透景生命总部及产业化基地",
    "href": "http://stock.jrj.com.cn/2022/12/12184137206653.shtml",
    "datetime": "2022-12-12 18:41:08",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：肌钙蛋白I测定试剂盒(胶乳免疫比浊法)取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/12/05185837189660.shtml",
    "datetime": "2022-12-05 18:58:16",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：张江创投拟减持不超3.6万股",
    "href": "http://stock.jrj.com.cn/2022/12/05185637189664.shtml",
    "datetime": "2022-12-05 18:56:40",
    "code": "300642"
  },
  {
    "title": "A股异动 | 透景生命(300642.SZ)跌逾4% 荣振投资拟减持不超488.3152万股",
    "href": "http://stock.jrj.com.cn/2022/11/23095637159736.shtml",
    "datetime": "2022-11-23 09:56:35",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：取得专利证书及软件著作权登记证书",
    "href": "http://stock.jrj.com.cn/2022/11/22195337158655.shtml",
    "datetime": "2022-11-22 19:53:08",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：荣振投资拟减持不超488.3152万股",
    "href": "http://stock.jrj.com.cn/2022/11/22195037158661.shtml",
    "datetime": "2022-11-22 19:50:22",
    "code": "300642"
  },
  {
    "title": "透景生命股东凌飞集团减持317.73万股 套现5487.13万 2022年前三季度公司净利8800万",
    "href": "http://stock.jrj.com.cn/2022/11/10201037128865.shtml",
    "datetime": "2022-11-10 20:10:33",
    "code": "300642"
  },
  {
    "title": "透景生命2022年前三季度净利8799.78万同比下滑16.64% 销售收入上升引起成本上升",
    "href": "http://stock.jrj.com.cn/2022/10/28193237095104.shtml",
    "datetime": "2022-10-28 19:32:50",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：子公司近日取得2项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/10/20180237070732.shtml",
    "datetime": "2022-10-20 18:02:09",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：凌飞集团于2021年11月9日至今以大宗交易减持270.1059万股",
    "href": "http://stock.jrj.com.cn/2022/09/02155536967919.shtml",
    "datetime": "2022-09-02 15:55:07",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)截至8月底已累计回购103.704万股",
    "href": "http://stock.jrj.com.cn/2022/09/02155236967923.shtml",
    "datetime": "2022-09-02 15:52:25",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：4项产品获得欧盟CE准入资质",
    "href": "http://stock.jrj.com.cn/2022/08/31185036959224.shtml",
    "datetime": "2022-08-31 18:50:26",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：拟2000万元参投产业投资基金金阖三期",
    "href": "http://stock.jrj.com.cn/2022/08/19200536917707.shtml",
    "datetime": "2022-08-19 20:05:35",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)上半年净利4311.17万元，同比下降42.37%",
    "href": "http://stock.jrj.com.cn/2022/08/19194536917653.shtml",
    "datetime": "2022-08-19 19:45:24",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：子公司取得23项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/08/18202836913528.shtml",
    "datetime": "2022-08-18 20:28:44",
    "code": "300642"
  },
  {
    "title": "透景生命：子公司近日取得11项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/08/03204536868019.shtml",
    "datetime": "2022-08-03 20:45:11",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：子公司近日取得11项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/08/03181936867497.shtml",
    "datetime": "2022-08-03 18:19:33",
    "code": "300642"
  },
  {
    "title": "透景生命：已回购约103.70万股 支付总金额为2493.48万元",
    "href": "http://stock.jrj.com.cn/2022/08/02103036862188.shtml",
    "datetime": "2022-08-02 10:30:38",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：截至7月底已累计回购103.704万股",
    "href": "http://stock.jrj.com.cn/2022/08/01204536860655.shtml",
    "datetime": "2022-08-01 20:45:07",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：近日取得4项专利证书",
    "href": "http://stock.jrj.com.cn/2022/08/01204336860657.shtml",
    "datetime": "2022-08-01 20:43:26",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：两款试剂盒产品取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/07/19182336825829.shtml",
    "datetime": "2022-07-19 18:23:08",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：截至6月底已累计回购103.704万股",
    "href": "http://stock.jrj.com.cn/2022/07/01191336776242.shtml",
    "datetime": "2022-07-01 19:13:57",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：取得2项专利证书",
    "href": "http://stock.jrj.com.cn/2022/06/29180236768573.shtml",
    "datetime": "2022-06-29 18:02:17",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：拟与脉势敬武等等设脉示生物、主要从事质谱相关业务",
    "href": "http://stock.jrj.com.cn/2022/06/20195336744102.shtml",
    "datetime": "2022-06-20 19:53:16",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：凌飞集团拟减持不超325.73万股",
    "href": "http://stock.jrj.com.cn/2022/06/08195036713660.shtml",
    "datetime": "2022-06-08 19:50:18",
    "code": "300642"
  },
  {
    "title": "透景生命股东凌飞集团质押300万股 用于补充流动资金",
    "href": "http://stock.jrj.com.cn/2022/06/07183136709876.shtml",
    "datetime": "2022-06-07 18:31:07",
    "code": "300642"
  },
  {
    "title": "透景生命：猴痘病毒核酸检测试剂盒等产品获得CE准入资质",
    "href": "http://stock.jrj.com.cn/2022/06/01132936696399.shtml",
    "datetime": "2022-06-01 13:29:39",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：部分产品近日取得欧盟CE准入资质",
    "href": "http://stock.jrj.com.cn/2022/05/31200536694468.shtml",
    "datetime": "2022-05-31 20:05:08",
    "code": "300642"
  },
  {
    "title": "透景生命股东荣振投资减持61.15万股 套现4130.71万 2021年公司净利1.61亿",
    "href": "http://stock.jrj.com.cn/2022/05/30215036691135.shtml",
    "datetime": "2022-05-30 21:50:08",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：减持期届满 荣振投资已减持61.15万股",
    "href": "http://stock.jrj.com.cn/2022/05/30201136690863.shtml",
    "datetime": "2022-05-30 20:11:08",
    "code": "300642"
  },
  {
    "title": "透景生命(300642)：特定股东减持股份计划届满暨实施情况",
    "href": "http://stock.jrj.com.cn/2022/05/30200336690801.shtml",
    "datetime": "2022-05-30 20:03:05",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：近日收到7项专利证书和1项计算机软件著作权登记证书",
    "href": "http://stock.jrj.com.cn/2022/05/24191936675114.shtml",
    "datetime": "2022-05-24 19:19:18",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：8项产品取得欧盟CE准入资质",
    "href": "http://stock.jrj.com.cn/2022/05/19201836663462.shtml",
    "datetime": "2022-05-19 20:18:58",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)2021年年度权益分派10派2.5元 股权登记日5月23日",
    "href": "http://stock.jrj.com.cn/2022/05/16182936652190.shtml",
    "datetime": "2022-05-16 18:29:22",
    "code": "300642"
  },
  {
    "title": "A股异动 | 透景生命涨7% 8项产品获美FDA批准",
    "href": "http://stock.jrj.com.cn/2022/05/13095636645360.shtml",
    "datetime": "2022-05-13 09:56:44",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：8项产品获得美国FDA批准",
    "href": "http://stock.jrj.com.cn/2022/05/12203736644170.shtml",
    "datetime": "2022-05-12 20:37:53",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)截至4月底已累计回购103.704万股",
    "href": "http://stock.jrj.com.cn/2022/05/05200036571517.shtml",
    "datetime": "2022-05-05 20:00:00",
    "code": "300642"
  },
  {
    "title": "透景生命2021年净利1.61亿同比增长33.62% 董事长姚见儿薪酬247.69万",
    "href": "http://stock.jrj.com.cn/2022/04/25051236454685.shtml",
    "datetime": "2022-04-25 05:12:26",
    "code": "300642"
  },
  {
    "title": "透景生命2022年第一季度净利527.01万同比减少77.1% 所得税费用同比减少",
    "href": "http://stock.jrj.com.cn/2022/04/24215136450783.shtml",
    "datetime": "2022-04-24 21:51:28",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：一季度净利降77.10%至527.01万元",
    "href": "http://stock.jrj.com.cn/2022/04/23115136435981.shtml",
    "datetime": "2022-04-23 11:51:07",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)2021年度净利升33.62%至1.61亿元 拟10派2.5元",
    "href": "http://stock.jrj.com.cn/2022/04/23114636435978.shtml",
    "datetime": "2022-04-23 11:46:38",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)截至3月底已累计回购55.23万股",
    "href": "http://stock.jrj.com.cn/2022/04/01162236247452.shtml",
    "datetime": "2022-04-01 16:22:47",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：19项产品获得CE准入资质",
    "href": "http://stock.jrj.com.cn/2022/03/29181436151571.shtml",
    "datetime": "2022-03-29 18:14:46",
    "code": "300642"
  },
  {
    "title": "透景生命：多款核酸检测试剂盒获欧盟CE准入资质",
    "href": "http://stock.jrj.com.cn/2022/03/29175636150657.shtml",
    "datetime": "2022-03-29 17:56:39",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：取得3项专利证书和6项计算机软件著作权登记证书",
    "href": "http://stock.jrj.com.cn/2022/03/09200234607053.shtml",
    "datetime": "2022-03-09 20:02:44",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：通过高新技术企业再次认定",
    "href": "http://stock.jrj.com.cn/2022/03/08184534542056.shtml",
    "datetime": "2022-03-08 18:45:15",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：截至2月底已累计回购50.45万股",
    "href": "http://stock.jrj.com.cn/2022/03/02185834513173.shtml",
    "datetime": "2022-03-02 18:58:41",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：全资子公司7项产品近日取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2022/02/18192034395201.shtml",
    "datetime": "2022-02-18 19:20:18",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：截至1月底已累计回购31.46万股",
    "href": "http://stock.jrj.com.cn/2022/02/08200134308776.shtml",
    "datetime": "2022-02-08 20:01:53",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：2019新冠病毒核酸检测试剂盒(卡式荧光PCR法)申报注册获受理",
    "href": "http://stock.jrj.com.cn/2022/01/10161034141393.shtml",
    "datetime": "2022-01-10 16:10:09",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：截至11月底已累计回购0.19%股份",
    "href": "http://stock.jrj.com.cn/2021/12/01174233950499.shtml",
    "datetime": "2021-12-01 17:42:12",
    "code": "300642"
  },
  {
    "title": "透景生命股东纽士达创投减持3.59万股 套现285.87万 第三季度公司净利3075.3万",
    "href": "http://stock.jrj.com.cn/2021/11/29231133940410.shtml",
    "datetime": "2021-11-29 23:11:08",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：减持期届满 纽士达创投已减持0.04%股份",
    "href": "http://stock.jrj.com.cn/2021/11/29200933939382.shtml",
    "datetime": "2021-11-29 20:09:28",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：1项体外诊断试剂获医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/11/18175333873352.shtml",
    "datetime": "2021-11-18 17:53:16",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：凌飞集团以大宗交易累计减持320万股",
    "href": "http://stock.jrj.com.cn/2021/11/16204633861900.shtml",
    "datetime": "2021-11-16 20:46:08",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：凌飞集团持股比例减少1.51%",
    "href": "http://stock.jrj.com.cn/2021/11/09183233828477.shtml",
    "datetime": "2021-11-09 18:32:32",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：11月3日首次回购10.68万股",
    "href": "http://stock.jrj.com.cn/2021/11/03175333809123.shtml",
    "datetime": "2021-11-03 17:53:57",
    "code": "300642"
  },
  {
    "title": "透景生命：拟回购2500万至5000万元公司股份 回购价格不超过50元/股",
    "href": "http://stock.jrj.com.cn/2021/10/27104233760119.shtml",
    "datetime": "2021-10-27 10:42:49",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：第三季度净利降27.24%至3075.299万元",
    "href": "http://stock.jrj.com.cn/2021/10/26215233757425.shtml",
    "datetime": "2021-10-26 21:52:01",
    "code": "300642"
  },
  {
    "title": "透景生命股东凌飞集团拟减持不超327.84万股公司股份 上半年公司净利7480.96万",
    "href": "http://stock.jrj.com.cn/2021/09/22194333500009.shtml",
    "datetime": "2021-09-22 19:43:51",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：持股11.23%的凌飞集团拟减持不超2%的股份",
    "href": "http://stock.jrj.com.cn/2021/09/22162933499107.shtml",
    "datetime": "2021-09-22 16:29:30",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)半年度权益分派10转8 股权登记日为9月15日",
    "href": "http://stock.jrj.com.cn/2021/09/09173333410217.shtml",
    "datetime": "2021-09-09 17:33:03",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：子公司取得1项专利证书",
    "href": "http://stock.jrj.com.cn/2021/09/02174933375023.shtml",
    "datetime": "2021-09-02 17:49:47",
    "code": "300642"
  },
  {
    "title": "A股异动丨透景生命(300642.SZ)大涨超8% 中期净利同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/08/23093633300885.shtml",
    "datetime": "2021-08-23 09:36:34",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)半年度业绩扭亏为盈至7480.96万元 拟10转8",
    "href": "http://stock.jrj.com.cn/2021/08/20205333289305.shtml",
    "datetime": "2021-08-20 20:53:47",
    "code": "300642"
  },
  {
    "title": "透景生命2021年半年度净利7480.96万元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/08/20204733289288.shtml",
    "datetime": "2021-08-20 20:47:32",
    "code": "300642"
  },
  {
    "title": "透景生命：上半年净利同比扭亏 拟每10股转增8股",
    "href": "http://stock.jrj.com.cn/2021/08/20203733289176.shtml",
    "datetime": "2021-08-20 20:37:31",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：拟出资1000万元参投产业投资基金 以投资生物医药相关领域",
    "href": "http://stock.jrj.com.cn/2021/08/06212733214691.shtml",
    "datetime": "2021-08-06 21:27:53",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：湖南透景体外诊断试剂产品取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/08/05174733208059.shtml",
    "datetime": "2021-08-05 17:47:02",
    "code": "300642"
  },
  {
    "title": "透景生命2021年上半年预计净利7000万-8200万同比扭亏为盈 各项工作有序开展",
    "href": "http://stock.jrj.com.cn/2021/08/03191333197248.shtml",
    "datetime": "2021-08-03 19:13:56",
    "code": "300642"
  },
  {
    "title": "A股异动丨透景生命(300642.SZ)午后拉升逾6% 上半年预盈7000万元-8200万元 同比扭亏",
    "href": "http://stock.jrj.com.cn/2021/08/03131533194451.shtml",
    "datetime": "2021-08-03 13:15:26",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)上半年预盈7000万元-8200万元 同比扭亏",
    "href": "http://stock.jrj.com.cn/2021/08/03115033194249.shtml",
    "datetime": "2021-08-03 11:50:42",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：全资子公司取得3项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/07/22175933136056.shtml",
    "datetime": "2021-07-22 17:59:11",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)2020年度权益分派10派4元 股权登记日为7月13日",
    "href": "http://stock.jrj.com.cn/2021/07/06201933054386.shtml",
    "datetime": "2021-07-06 20:19:40",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：全资子公司取得7项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/06/29190233017110.shtml",
    "datetime": "2021-06-29 19:02:06",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：子公司取得1项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/06/08152732893335.shtml",
    "datetime": "2021-06-08 15:27:57",
    "code": "300642"
  },
  {
    "title": "透景生命：公司目前营业收入的主要来源是肿瘤标志物检测产品和HPV检测产品",
    "href": "http://stock.jrj.com.cn/2021/05/27162432830164.shtml",
    "datetime": "2021-05-27 16:24:12",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：荣振投资拟减持不超2%的股份",
    "href": "http://stock.jrj.com.cn/2021/05/24211232812548.shtml",
    "datetime": "2021-05-24 21:12:55",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：纽士达创投拟减持不超2%的股份",
    "href": "http://stock.jrj.com.cn/2021/05/24211132812535.shtml",
    "datetime": "2021-05-24 21:11:35",
    "code": "300642"
  },
  {
    "title": "透景生命：公司自身抗体谱检测试剂盒已参与北京协和医院试剂采购招标项目目前正在等待招标结果",
    "href": "http://stock.jrj.com.cn/2021/05/24190732811941.shtml",
    "datetime": "2021-05-24 19:07:52",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：取得1项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/05/14212632757443.shtml",
    "datetime": "2021-05-14 21:26:04",
    "code": "300642"
  },
  {
    "title": "透景生命：自身免疫领域检测场景就适合流式荧光 有利于缩短检测时间",
    "href": "http://stock.jrj.com.cn/2021/05/10095632727214.shtml",
    "datetime": "2021-05-10 09:56:51",
    "code": "300642"
  },
  {
    "title": "透景生命：目前TESMI i100化学发光免疫分析仪正处于市场推广期",
    "href": "http://stock.jrj.com.cn/2021/05/10095032727166.shtml",
    "datetime": "2021-05-10 09:50:51",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：上海启明已累计减持4.985%的股份",
    "href": "http://stock.jrj.com.cn/2021/04/30195132489042.shtml",
    "datetime": "2021-04-30 19:51:07",
    "code": "300642"
  },
  {
    "title": "透景生命：公司已建立了一个覆盖全国31个省市的经销商网络",
    "href": "http://stock.jrj.com.cn/2021/04/30091732484680.shtml",
    "datetime": "2021-04-30 09:17:01",
    "code": "300642"
  },
  {
    "title": "透景生命：公司部分新型冠状病毒检测试剂盒和配套检验及仪器的海外销售主要面向欧盟、东南亚等",
    "href": "http://stock.jrj.com.cn/2021/04/30091632484678.shtml",
    "datetime": "2021-04-30 09:16:29",
    "code": "300642"
  },
  {
    "title": "透景生命2020年净利减少23.22% 董事长姚见儿薪酬162.92万",
    "href": "http://stock.jrj.com.cn/2021/04/24173632435384.shtml",
    "datetime": "2021-04-24 17:36:36",
    "code": "300642"
  },
  {
    "title": "透景生命2021年第一季度净利2300.94万较上年同期扭亏为盈 管理人员增加",
    "href": "http://stock.jrj.com.cn/2021/04/24173432435372.shtml",
    "datetime": "2021-04-24 17:34:00",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)一季度净利达2300.94万元 同比扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/04/23234132432860.shtml",
    "datetime": "2021-04-23 23:41:04",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)2020年净利降23.22%至1.21亿元 拟10派4元",
    "href": "http://stock.jrj.com.cn/2021/04/23233732432856.shtml",
    "datetime": "2021-04-23 23:37:10",
    "code": "300642"
  },
  {
    "title": "透景生命：公司自身免疫检测产品已于本年一季度陆续开展进院工作",
    "href": "http://stock.jrj.com.cn/2021/04/21100832414754.shtml",
    "datetime": "2021-04-21 10:08:34",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：子公司取得1项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/04/11152632348251.shtml",
    "datetime": "2021-04-11 15:26:49",
    "code": "300642"
  },
  {
    "title": "透景生命2021年第一季度预计净利2000万-2600万 较上年同期扭亏为盈",
    "href": "http://stock.jrj.com.cn/2021/04/07225632327980.shtml",
    "datetime": "2021-04-07 22:56:24",
    "code": "300642"
  },
  {
    "title": "透景生命2020年度净利下滑21.55% 新冠相关耗材及设备毛利率相对较低",
    "href": "http://stock.jrj.com.cn/2021/04/07224332327926.shtml",
    "datetime": "2021-04-07 22:43:16",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)业绩快报：2020年度净利降21.55%至1.23亿元",
    "href": "http://stock.jrj.com.cn/2021/04/07204132327335.shtml",
    "datetime": "2021-04-07 20:41:55",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：2021年一季度扭亏为盈 预盈2000万元-2600万元",
    "href": "http://stock.jrj.com.cn/2021/04/07203932327321.shtml",
    "datetime": "2021-04-07 20:39:07",
    "code": "300642"
  },
  {
    "title": "透景生命股东张江创投减持326.16万股 套现1.73亿",
    "href": "http://stock.jrj.com.cn/2021/04/02213932272578.shtml",
    "datetime": "2021-04-02 21:39:38",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：张江创投已减持3.58%的股份",
    "href": "http://stock.jrj.com.cn/2021/04/02184632271657.shtml",
    "datetime": "2021-04-02 18:46:09",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：申报医疗器械注册获得受理",
    "href": "http://stock.jrj.com.cn/2021/04/01182432264224.shtml",
    "datetime": "2021-04-01 18:24:19",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：取得1项医疗器械注册证、部分产品取得欧盟CE准入资质",
    "href": "http://stock.jrj.com.cn/2021/04/01182232264219.shtml",
    "datetime": "2021-04-01 18:22:27",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：申报医疗器械注册获得受理",
    "href": "http://stock.jrj.com.cn/2021/03/23200932203524.shtml",
    "datetime": "2021-03-23 20:09:14",
    "code": "300642"
  },
  {
    "title": "透景生命：公司及全资子公司申报医疗器械注册获得受理",
    "href": "http://stock.jrj.com.cn/2021/03/18140832156843.shtml",
    "datetime": "2021-03-18 14:08:50",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)及全资子公司12项医疗器械注册申请获受理",
    "href": "http://stock.jrj.com.cn/2021/03/18115932156312.shtml",
    "datetime": "2021-03-18 11:59:38",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：取得2项专利证书",
    "href": "http://stock.jrj.com.cn/2021/03/09180032098678.shtml",
    "datetime": "2021-03-09 18:00:25",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：1,5-脱水葡糖醇测定试剂盒(酶法)取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2021/02/19183031993784.shtml",
    "datetime": "2021-02-19 18:30:06",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：聘任张佳锦担任公司财务负责人",
    "href": "http://stock.jrj.com.cn/2021/02/18190631987947.shtml",
    "datetime": "2021-02-18 19:06:28",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：财务负责人范杰辞职",
    "href": "http://stock.jrj.com.cn/2021/02/10182431884215.shtml",
    "datetime": "2021-02-10 18:24:13",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：10项产品获得CE准入资质",
    "href": "http://stock.jrj.com.cn/2021/01/04191131628707.shtml",
    "datetime": "2021-01-04 19:11:24",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)与子公司取得1项专利证书及1项软件著作权登记证书",
    "href": "http://stock.jrj.com.cn/2020/12/30200931606593.shtml",
    "datetime": "2020-12-30 20:09:31",
    "code": "300642"
  },
  {
    "title": "透景生命股东凌飞集团质押310万股 用于补充流动资金",
    "href": "http://stock.jrj.com.cn/2020/12/25200231572254.shtml",
    "datetime": "2020-12-25 20:02:31",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：股东凌飞集团质押310万股",
    "href": "http://stock.jrj.com.cn/2020/12/25155231570343.shtml",
    "datetime": "2020-12-25 15:52:16",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：股东凌飞集团解除质押708.52万股",
    "href": "http://stock.jrj.com.cn/2020/12/22202731547220.shtml",
    "datetime": "2020-12-22 20:27:51",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：凌飞集团减持期届满 累计减持2.54%股份",
    "href": "http://stock.jrj.com.cn/2020/12/16202531504303.shtml",
    "datetime": "2020-12-16 20:25:54",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)拟推218万份股票期权与限制性股票激励计划",
    "href": "http://stock.jrj.com.cn/2020/12/14204531489119.shtml",
    "datetime": "2020-12-14 20:45:26",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：子公司取得2项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2020/11/30201031378141.shtml",
    "datetime": "2020-11-30 20:10:55",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)取得1项计算机软件著作权登记证书",
    "href": "http://stock.jrj.com.cn/2020/11/30201031378143.shtml",
    "datetime": "2020-11-30 20:10:05",
    "code": "300642"
  },
  {
    "title": "透景生命2020年前三季度净利3365.19万下滑65.72% 营业外支出同比增长",
    "href": "http://stock.jrj.com.cn/2020/10/23222431119321.shtml",
    "datetime": "2020-10-23 22:24:52",
    "code": "300642"
  },
  {
    "title": "透景生命(300642.SZ)：凌飞集团减持期过半 累计减持1%股份",
    "href": "http://stock.jrj.com.cn/2020/09/17114830768519.shtml",
    "datetime": "2020-09-17 11:48:45",
    "code": "300642"
  },
  {
    "title": "透景生命股东上海启明减持15.25万股 套现约737.64万元",
    "href": "http://stock.jrj.com.cn/2020/09/02205330662796.shtml",
    "datetime": "2020-09-02 20:53:41",
    "code": "300642"
  },
  {
    "title": "大消费板块受青睐 外资举牌透景生命",
    "href": "http://stock.jrj.com.cn/2020/08/22081230562106.shtml",
    "datetime": "2020-08-22 08:12:53",
    "code": "300642"
  },
  {
    "title": "透景生命2020年上半年亏损861.2万由盈转亏 终端用户检测量下降",
    "href": "http://stock.jrj.com.cn/2020/08/22074730561862.shtml",
    "datetime": "2020-08-22 07:47:18",
    "code": "300642"
  },
  {
    "title": "透景生命：子公司取得4项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2020/07/03222930136996.shtml",
    "datetime": "2020-07-03 22:29:16",
    "code": "300642"
  },
  {
    "title": "透景生命：上海启明累计减持1.16%股份",
    "href": "http://stock.jrj.com.cn/2020/06/10200229892205.shtml",
    "datetime": "2020-06-10 20:02:00",
    "code": "300642"
  },
  {
    "title": "透景生命：纽士达创投计划减持不超过3%的股份",
    "href": "http://stock.jrj.com.cn/2020/06/02192129829188.shtml",
    "datetime": "2020-06-02 19:21:00",
    "code": "300642"
  },
  {
    "title": "透景生命：股东纽士达创投拟减持不超过总股本3%",
    "href": "http://stock.jrj.com.cn/2020/06/02182029828636.shtml",
    "datetime": "2020-06-02 18:20:24",
    "code": "300642"
  },
  {
    "title": "透景生命股东荣振投资减持11万股 套现约532万元",
    "href": "http://stock.jrj.com.cn/2020/05/25193829761800.shtml",
    "datetime": "2020-05-25 19:38:29",
    "code": "300642"
  },
  {
    "title": "透景生命:股东凌飞集团拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2020/05/25193629761598.shtml",
    "datetime": "2020-05-25 19:36:07",
    "code": "300642"
  },
  {
    "title": "透景生命：股东凌飞集团拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2020/05/25154029759957.shtml",
    "datetime": "2020-05-25 15:40:24",
    "code": "300642"
  },
  {
    "title": "透景生命高级管理人员周爱国减持75万股 套现约3665万元",
    "href": "http://stock.jrj.com.cn/2020/05/21230029733848.shtml",
    "datetime": "2020-05-21 23:00:16",
    "code": "300642"
  },
  {
    "title": "透景生命：全资子公司申报医疗器械注册获得受理",
    "href": "http://stock.jrj.com.cn/2020/05/19205629714182.shtml",
    "datetime": "2020-05-19 20:56:40",
    "code": "300642"
  },
  {
    "title": "透景生命拟参与设立产业投资基金 公司出资金额为5000万元",
    "href": "http://stock.jrj.com.cn/2020/05/18192129704365.shtml",
    "datetime": "2020-05-18 19:21:50",
    "code": "300642"
  },
  {
    "title": "透景生命聘任范杰担任公司财务负责人",
    "href": "http://stock.jrj.com.cn/2020/05/18191229704323.shtml",
    "datetime": "2020-05-18 19:12:24",
    "code": "300642"
  },
  {
    "title": "透景生命：拟5000万元参设合伙企业 有助于推动公司体外诊断领域业务扩展",
    "href": "http://stock.jrj.com.cn/2020/05/18164029703070.shtml",
    "datetime": "2020-05-18 16:40:17",
    "code": "300642"
  },
  {
    "title": "透景生命财务负责人刘娟辞职 2019年薪酬56万元",
    "href": "http://stock.jrj.com.cn/2020/05/15220129684463.shtml",
    "datetime": "2020-05-15 22:01:46",
    "code": "300642"
  },
  {
    "title": "透景生命股东上海启明拟减持股份 预计减持不超过469.23万股",
    "href": "http://stock.jrj.com.cn/2020/05/11215529644135.shtml",
    "datetime": "2020-05-11 21:55:47",
    "code": "300642"
  },
  {
    "title": "透景生命：持公司5.17%股份股东上海启明计划清仓减持",
    "href": "http://stock.jrj.com.cn/2020/05/11201729643224.shtml",
    "datetime": "2020-05-11 20:17:39",
    "code": "300642"
  },
  {
    "title": "透景生命：持公司5.17%股份的股东上海启明计划清仓减持",
    "href": "http://stock.jrj.com.cn/2020/05/11201329643194.shtml",
    "datetime": "2020-05-11 20:13:34",
    "code": "300642"
  },
  {
    "title": "透景生命股东上海启明拟减持不超5.17%股份",
    "href": "http://stock.jrj.com.cn/2020/05/11200229643166.shtml",
    "datetime": "2020-05-11 20:02:31",
    "code": "300642"
  },
  {
    "title": "透景生命2020年一季度亏损1907.57万由盈转亏 经销商复工时间延迟",
    "href": "http://stock.jrj.com.cn/2020/04/26223329379370.shtml",
    "datetime": "2020-04-26 22:33:45",
    "code": "300642"
  },
  {
    "title": "透景生命2019年净利1.57亿增长10.82% 市场占有率继续提升",
    "href": "http://stock.jrj.com.cn/2020/04/25155329374561.shtml",
    "datetime": "2020-04-25 15:53:24",
    "code": "300642"
  },
  {
    "title": "透景生命：全资子公司取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2020/04/23212929360758.shtml",
    "datetime": "2020-04-23 21:29:08",
    "code": "300642"
  },
  {
    "title": "透景生命：特定股东张江创投拟减持不超过3.61%公司股份",
    "href": "http://stock.jrj.com.cn/2020/03/30214329149688.shtml",
    "datetime": "2020-03-30 21:43:58",
    "code": "300642"
  },
  {
    "title": "透景生命特定股东张江创投拟减持328.16万股 预计减持不超总股本3.61%",
    "href": "http://stock.jrj.com.cn/2020/03/30213229149629.shtml",
    "datetime": "2020-03-30 21:32:57",
    "code": "300642"
  },
  {
    "title": "透景生命：特定股东张江创投拟减持不超过3.61%股份",
    "href": "http://stock.jrj.com.cn/2020/03/30175429148273.shtml",
    "datetime": "2020-03-30 17:54:57",
    "code": "300642"
  },
  {
    "title": "透景生命新型冠状病毒检测产品获得欧盟CE准入资质",
    "href": "http://stock.jrj.com.cn/2020/03/27193729129461.shtml",
    "datetime": "2020-03-27 19:37:46",
    "code": "300642"
  },
  {
    "title": "透景生命：7项新冠病毒检测产品取得欧盟CE准入资质 有助于进一步增强公司产品竞争力",
    "href": "http://stock.jrj.com.cn/2020/03/27164029127733.shtml",
    "datetime": "2020-03-27 16:40:58",
    "code": "300642"
  },
  {
    "title": "透景生命：新型冠状病毒检测产品获得欧盟CE准入资质",
    "href": "http://stock.jrj.com.cn/2020/03/27160929127594.shtml",
    "datetime": "2020-03-27 16:09:00",
    "code": "300642"
  },
  {
    "title": "透景生命：新冠病毒检测产品获得欧盟CE准入资质",
    "href": "http://stock.jrj.com.cn/2020/03/27160729127549.shtml",
    "datetime": "2020-03-27 16:07:17",
    "code": "300642"
  },
  {
    "title": "透景生命：上海透景三项体外诊断试剂获医疗器械注册证 将丰富公司产品种类",
    "href": "http://stock.jrj.com.cn/2020/03/26174029119128.shtml",
    "datetime": "2020-03-26 17:40:09",
    "code": "300642"
  },
  {
    "title": "透景生命：取得3项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2020/03/26154729118350.shtml",
    "datetime": "2020-03-26 15:47:00",
    "code": "300642"
  },
  {
    "title": "透景生命：取得4项医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2020/03/24162929095075.shtml",
    "datetime": "2020-03-24 16:29:00",
    "code": "300642"
  },
  {
    "title": "透景生命股东张江创投减持172万股 套现约7776万元",
    "href": "http://stock.jrj.com.cn/2020/03/20190029071261.shtml",
    "datetime": "2020-03-20 19:00:56",
    "code": "300642"
  },
  {
    "title": "透景生命：股东拟继续减持不超过2%股份",
    "href": "http://stock.jrj.com.cn/2020/03/20180529070911.shtml",
    "datetime": "2020-03-20 18:05:59",
    "code": "300642"
  },
  {
    "title": "透景生命：股东拟继续减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2020/03/20173629070327.shtml",
    "datetime": "2020-03-20 17:36:00",
    "code": "300642"
  },
  {
    "title": "透景生命：2019年度业绩快报",
    "href": "http://stock.jrj.com.cn/2020/02/24191028883684.shtml",
    "datetime": "2020-02-24 19:10:00",
    "code": "300642"
  },
  {
    "title": "透景生命2019年净利1.56亿 同比增长10.06%",
    "href": "http://stock.jrj.com.cn/2020/02/24185028883598.shtml",
    "datetime": "2020-02-24 18:50:17",
    "code": "300642"
  },
  {
    "title": "透景生命：2019年净利1.56亿元 同比增长10%。",
    "href": "http://stock.jrj.com.cn/2020/02/24161828882784.shtml",
    "datetime": "2020-02-24 16:18:29",
    "code": "300642"
  },
  {
    "title": "启明维创(上海)股权投资中心因违规减持透景生命收深交所监管函",
    "href": "http://stock.jrj.com.cn/2020/02/11165328810088.shtml",
    "datetime": "2020-02-11 16:53:00",
    "code": "300642"
  },
  {
    "title": "透景生命：公司完成新型冠状病毒检测产品研制 尚需审批",
    "href": "http://stock.jrj.com.cn/2020/02/02172828748774.shtml",
    "datetime": "2020-02-02 17:28:29",
    "code": "300642"
  },
  {
    "title": "透景生命：完成新型冠状病毒检测试剂研制",
    "href": "http://stock.jrj.com.cn/2020/02/02172628748766.shtml",
    "datetime": "2020-02-02 17:26:06",
    "code": "300642"
  },
  {
    "title": "透景生命预计2019年盈利1.42亿元至1.63亿元 同比增长0%至15%",
    "href": "http://stock.jrj.com.cn/2020/01/21115728712574.shtml",
    "datetime": "2020-01-21 11:57:11",
    "code": "300642"
  },
  {
    "title": "透景生命股东上海启明减持194万股 套现约7418万元",
    "href": "http://stock.jrj.com.cn/2020/01/10214728660250.shtml",
    "datetime": "2020-01-10 21:47:44",
    "code": "300642"
  },
  {
    "title": "透景生命股东拟减持181.64万股 不超总股本的2%",
    "href": "http://stock.jrj.com.cn/2019/11/29140528467977.shtml",
    "datetime": "2019-11-29 14:05:31",
    "code": "300642"
  },
  {
    "title": "透景生命股东凌飞集团质押454万股 2019年上半年净利同比增长6%",
    "href": "http://stock.jrj.com.cn/2019/11/11215328382036.shtml",
    "datetime": "2019-11-11 21:53:44",
    "code": "300642"
  },
  {
    "title": "透景生命第三季度盈利1.17亿 同比增长17%",
    "href": "http://stock.jrj.com.cn/2019/10/25222328302674.shtml",
    "datetime": "2019-10-25 22:23:30",
    "code": "300642"
  },
  {
    "title": "透景生命：2019年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/10/14212028245184.shtml",
    "datetime": "2019-10-14 21:20:02",
    "code": "300642"
  },
  {
    "title": "透景生命2019年前三季度净利约9558万元-1.05亿元 销售收入规模持续扩大",
    "href": "http://stock.jrj.com.cn/2019/10/14210628245106.shtml",
    "datetime": "2019-10-14 21:06:03",
    "code": "300642"
  },
  {
    "title": "透景生命股东凌飞集团质押254.52万股用于生产经营",
    "href": "http://stock.jrj.com.cn/2019/09/19210728155459.shtml",
    "datetime": "2019-09-19 21:07:28",
    "code": "300642"
  },
  {
    "title": "透景生命使用部分闲置自有资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2019/09/03082628081299.shtml",
    "datetime": "2019-09-03 08:26:25",
    "code": "300642"
  },
  {
    "title": "透景生命股东张江创投拟减持股份 预计减持不超总股本2%",
    "href": "http://stock.jrj.com.cn/2019/08/30092628060378.shtml",
    "datetime": "2019-08-30 09:26:31",
    "code": "300642"
  },
  {
    "title": "透景生命：持股5.5%的股东拟减持不超2%",
    "href": "http://stock.jrj.com.cn/2019/08/29174128056758.shtml",
    "datetime": "2019-08-29 17:41:07",
    "code": "300642"
  },
  {
    "title": "透景生命：张江创投拟减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2019/08/29172328056384.shtml",
    "datetime": "2019-08-29 17:23:00",
    "code": "300642"
  },
  {
    "title": "透景生命股东张江创投减持184万股 套现约7979万元",
    "href": "http://stock.jrj.com.cn/2019/08/27110128039538.shtml",
    "datetime": "2019-08-27 11:01:36",
    "code": "300642"
  },
  {
    "title": "透景生命股东上海启明拟减持股份 预计减持不超总股本3%",
    "href": "http://stock.jrj.com.cn/2019/08/17195827991371.shtml",
    "datetime": "2019-08-17 19:58:47",
    "code": "300642"
  },
  {
    "title": "透景生命：持股7.93%的股东上海启明拟减持不超3%",
    "href": "http://stock.jrj.com.cn/2019/08/16190627989169.shtml",
    "datetime": "2019-08-16 19:06:26",
    "code": "300642"
  },
  {
    "title": "透景生命：上海启明拟减持不超过3%公司股份",
    "href": "http://stock.jrj.com.cn/2019/08/16181927988939.shtml",
    "datetime": "2019-08-16 18:19:18",
    "code": "300642"
  },
  {
    "title": "透景生命股东上海启明拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2019/08/16180827988896.shtml",
    "datetime": "2019-08-16 18:08:48",
    "code": "300642"
  },
  {
    "title": "透景生命：上海启明拟减持公司不超3%股权",
    "href": "http://stock.jrj.com.cn/2019/08/16180827988902.shtml",
    "datetime": "2019-08-16 18:08:00",
    "code": "300642"
  },
  {
    "title": "透景生命股东荣振投资减持48万股 套现约2171万元",
    "href": "http://stock.jrj.com.cn/2019/07/23074327874798.shtml",
    "datetime": "2019-07-23 07:43:35",
    "code": "300642"
  },
  {
    "title": "透景生命：2019年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/07/10195027823307.shtml",
    "datetime": "2019-07-10 19:50:00",
    "code": "300642"
  },
  {
    "title": "透景生命上半年预计盈利5144万元 经营稳定与去年同期持平",
    "href": "http://stock.jrj.com.cn/2019/07/10164227822376.shtml",
    "datetime": "2019-07-10 16:42:56",
    "code": "300642"
  },
  {
    "title": "透景生命：2018年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2019/07/05220027803520.shtml",
    "datetime": "2019-07-05 22:00:00",
    "code": "300642"
  },
  {
    "title": "透景生命股东上海启明减持91万股 套现约3938万元",
    "href": "http://stock.jrj.com.cn/2019/06/19073327722952.shtml",
    "datetime": "2019-06-19 07:33:49",
    "code": "300642"
  },
  {
    "title": "透景生命股东荣振投资质押192万股 公司去年净利同比增长12%",
    "href": "http://stock.jrj.com.cn/2019/05/21230527603479.shtml",
    "datetime": "2019-05-21 23:05:17",
    "code": "300642"
  },
  {
    "title": "透景生命：关于2017年限制性股票激励计划第一个解除限售期解除限售股份上市流通的提示性公告",
    "href": "http://stock.jrj.com.cn/2019/04/30212027515920.shtml",
    "datetime": "2019-04-30 21:20:00",
    "code": "300642"
  },
  {
    "title": "透景生命：2018年净利同比增12% 拟10派3元",
    "href": "http://stock.jrj.com.cn/2019/04/24225727476742.shtml",
    "datetime": "2019-04-24 22:57:31",
    "code": "300642"
  },
  {
    "title": "透景生命：2018年净利润同比增长11.73％ 拟10派3元",
    "href": "http://stock.jrj.com.cn/2019/04/24191427475889.shtml",
    "datetime": "2019-04-24 19:14:15",
    "code": "300642"
  },
  {
    "title": "透景生命：股东张江创投减持公司1.04%股份",
    "href": "http://stock.jrj.com.cn/2019/03/05165927121253.shtml",
    "datetime": "2019-03-05 16:59:06",
    "code": "300642"
  },
  {
    "title": "透景生命股东荣振投资质押5万股 公司上年净利同比增长20%",
    "href": "http://stock.jrj.com.cn/2019/02/13221727039991.shtml",
    "datetime": "2019-02-13 22:17:12",
    "code": "300642"
  },
  {
    "title": "透景生命股东荣振投资补充质押10万股 其所持64%被质押",
    "href": "http://stock.jrj.com.cn/2019/01/31220627009811.shtml",
    "datetime": "2019-01-31 22:06:58",
    "code": "300642"
  },
  {
    "title": "透景生命：张江创投拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2019/01/24172226952408.shtml",
    "datetime": "2019-01-24 17:22:39",
    "code": "300642"
  },
  {
    "title": "透景生命：2018年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/01/22183026942392.shtml",
    "datetime": "2019-01-22 18:30:00",
    "code": "300642"
  },
  {
    "title": "透景生命：股东荣振投资拟减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2018/12/24212726795599.shtml",
    "datetime": "2018-12-24 21:27:22",
    "code": "300642"
  },
  {
    "title": "透景生命股东上海启明拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2018/12/13195226736433.shtml",
    "datetime": "2018-12-13 19:52:08",
    "code": "300642"
  },
  {
    "title": "透景生命股东拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2018/12/13194026736381.shtml",
    "datetime": "2018-12-13 19:40:14",
    "code": "300642"
  },
  {
    "title": "透景生命：股东拟减持不超3%股份",
    "href": "http://stock.jrj.com.cn/2018/12/13193026736353.shtml",
    "datetime": "2018-12-13 19:30:00",
    "code": "300642"
  },
  {
    "title": "透景生命：2018年前三季度报告主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/10/17203025217501.shtml",
    "datetime": "2018-10-17 20:30:01",
    "code": "300642"
  },
  {
    "title": "透景生命：前三季净利9103万元 同比增17.65%",
    "href": "http://stock.jrj.com.cn/2018/10/17173525216985.shtml",
    "datetime": "2018-10-17 17:35:00",
    "code": "300642"
  },
  {
    "title": "[透景生命]会议|第八届中国病理年会圆满召开,透景肺癌甲基化Lung-MeTM再掀热潮",
    "href": "http://stock.jrj.com.cn/2018/10/17000025217012.shtml",
    "datetime": "2018-10-17 00:00:00",
    "code": "300642"
  },
  {
    "title": "[透景生命]重磅喜讯!透景生命姚见儿先生入选科技创新创业人才名单",
    "href": "http://stock.jrj.com.cn/2018/10/15000025204058.shtml",
    "datetime": "2018-10-15 00:00:00",
    "code": "300642"
  },
  {
    "title": "透景生命：收入增速回暖，业绩再回高增长超预期",
    "href": "http://stock.jrj.com.cn/2018/10/12160225195995.shtml",
    "datetime": "2018-10-12 16:02:00",
    "code": "300642"
  },
  {
    "title": "透景生命：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/11210025189493.shtml",
    "datetime": "2018-10-11 21:00:00",
    "code": "300642"
  },
  {
    "title": "[透景生命]喜讯|透景生命荣获上海科技企业孵化器“明星科创企业奖”",
    "href": "http://stock.jrj.com.cn/2018/10/11000025188551.shtml",
    "datetime": "2018-10-11 00:00:00",
    "code": "300642"
  },
  {
    "title": "透景生命：药品集中采购试点未覆盖体外诊断产品领域",
    "href": "http://stock.jrj.com.cn/2018/09/14141525092327.shtml",
    "datetime": "2018-09-14 14:15:00",
    "code": "300642"
  },
  {
    "title": "透景生命半年报员工构成引关注 营销人员大涨，员工总数仅微增",
    "href": "http://stock.jrj.com.cn/2018/08/27222725007634.shtml",
    "datetime": "2018-08-27 22:27:42",
    "code": "300642"
  },
  {
    "title": "[透景生命]流式荧光技术——更灵活、高效的多重联检技术",
    "href": "http://stock.jrj.com.cn/2018/08/14000024950256.shtml",
    "datetime": "2018-08-14 00:00:00",
    "code": "300642"
  },
  {
    "title": "透景生命：张江创投拟减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2018/06/25213024725474.shtml",
    "datetime": "2018-06-25 21:30:00",
    "code": "300642"
  },
  {
    "title": "透景生命股东计划减持不超过182万股",
    "href": "http://stock.jrj.com.cn/2018/06/25193824725189.shtml",
    "datetime": "2018-06-25 19:38:00",
    "code": "300642"
  },
  {
    "title": "透景生命年报推10转5派4元 股权登记5月28日",
    "href": "http://stock.jrj.com.cn/2018/05/22205024575680.shtml",
    "datetime": "2018-05-22 20:50:58",
    "code": "300642"
  },
  {
    "title": "透景生命：上海启明拟减持不超2.5%股份",
    "href": "http://stock.jrj.com.cn/2018/05/21212524570138.shtml",
    "datetime": "2018-05-21 21:25:00",
    "code": "300642"
  },
  {
    "title": "[透景生命]ASCCP荣耀归来郄明蓉教授将莅临CSCCP卫星会再现精彩",
    "href": "http://stock.jrj.com.cn/2018/05/18000024559437.shtml",
    "datetime": "2018-05-18 00:00:00",
    "code": "300642"
  },
  {
    "title": "[透景生命]喜讯 | 第一届YEQA质控计划取得圆满成功",
    "href": "http://stock.jrj.com.cn/2018/05/08000024509846.shtml",
    "datetime": "2018-05-08 00:00:00",
    "code": "300642"
  },
  {
    "title": "透景生命净利增29.71% 年报拟10转5派4元",
    "href": "http://stock.jrj.com.cn/2018/04/19095924414895.shtml",
    "datetime": "2018-04-19 09:59:49",
    "code": "300642"
  },
  {
    "title": "透景生命：2017年净利同比增29.71% 拟10转5派4元",
    "href": "http://stock.jrj.com.cn/hotstock/2018/04/19075924414197.shtml",
    "datetime": "2018-04-19 07:59:58",
    "code": "300642"
  },
  {
    "title": "透景生命：2017年净利同比增三成 拟10转5派4元",
    "href": "http://stock.jrj.com.cn/2018/04/18202524411982.shtml",
    "datetime": "2018-04-18 20:25:00",
    "code": "300642"
  },
  {
    "title": "透景生命2017年度利润分配拟10转5派4元",
    "href": "http://stock.jrj.com.cn/2018/04/18201024411936.shtml",
    "datetime": "2018-04-18 20:10:00",
    "code": "300642"
  },
  {
    "title": "透景生命子公司取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2018/03/30120324327947.shtml",
    "datetime": "2018-03-30 12:03:00",
    "code": "300642"
  },
  {
    "title": "[透景生命]我们和春天有个约会",
    "href": "http://stock.jrj.com.cn/2018/03/08000024234847.shtml",
    "datetime": "2018-03-08 00:00:00",
    "code": "300642"
  },
  {
    "title": "透景生命取得医疗器械注册证",
    "href": "http://stock.jrj.com.cn/2017/12/01172423728399.shtml",
    "datetime": "2017-12-01 17:24:00",
    "code": "300642"
  },
  {
    "title": "[透景生命]创新促民生|透景生命亮相中华医学会第十三次妇产科学学术大会",
    "href": "http://stock.jrj.com.cn/2017/11/07000024021836.shtml",
    "datetime": "2017-11-07 00:00:00",
    "code": "300642"
  },
  {
    "title": "透景生命(300642)中签率为0.0123% 认购倍数为8114.43倍",
    "href": "http://stock.jrj.com.cn/ipo/2017/04/13093022307385.shtml",
    "datetime": "2017-04-13 09:30:00",
    "code": "300642"
  }
]